|
Name |
Octadecanedioic acid
|
Molecular Formula | C18H34O4 | |
IUPAC Name* |
octadecanedioic acid
|
|
SMILES |
C(CCCCCCCCC(=O)O)CCCCCCCC(=O)O
|
|
InChI |
InChI=1S/C18H34O4/c19-17(20)15-13-11-9-7-5-3-1-2-4-6-8-10-12-14-16-18(21)22/h1-16H2,(H,19,20)(H,21,22)
|
|
InChIKey |
BNJOQKFENDDGSC-UHFFFAOYSA-N
|
|
Synonyms |
Octadecanedioic acid; 871-70-5; 1,18-Octadecanedioic acid; 1,16-Hexadecanedicarboxylic acid; Octadecane-1,18-dioic acid; RSZ6PQ0QQJ; Hexadecanedicarboxylic acid; 1,18-Octadecadioic acid; Octadecanedioate; MFCD00142369; 1,18-Octadecanedioate; 1,16-Hexadecanedicarboxylate; UNII-RSZ6PQ0QQJ; ODDA; 18-octadecanedioic acid; OCTADECANEDIOICACID; SCHEMBL35775; AMY042; DTXSID1074331; CHEBI:133086; 1,16-hexadecane dicarboxylic acid; BCP32531; ZINC5178630; LMFA01170029; AKOS015839857; CS-W005178; GS-3421; HY-W005178; AC-32514; SY025879; FT-0700803; O0222; 871O705; A842023; 1,18-Octadecadioic acid;Octadecane-1,18-dioic acid; Q27288272
|
|
CAS | 871-70-5 | |
PubChem CID | 70095 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 314.5 | ALogp: | 6.4 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 17 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 74.6 | Aromatic Rings: | 0 |
Heavy Atoms: | 22 | QED Weighted: | 0.341 |
Caco-2 Permeability: | -5.478 | MDCK Permeability: | 0.00004330 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.02 | 20% Bioavailability (F20%): | 0.876 |
30% Bioavailability (F30%): | 0.986 |
Blood-Brain-Barrier Penetration (BBB): | 0.005 | Plasma Protein Binding (PPB): | 98.97% |
Volume Distribution (VD): | 0.448 | Fu: | 0.61% |
CYP1A2-inhibitor: | 0.065 | CYP1A2-substrate: | 0.15 |
CYP2C19-inhibitor: | 0.02 | CYP2C19-substrate: | 0.075 |
CYP2C9-inhibitor: | 0.131 | CYP2C9-substrate: | 0.995 |
CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.053 |
CYP3A4-inhibitor: | 0.003 | CYP3A4-substrate: | 0.005 |
Clearance (CL): | 1.49 | Half-life (T1/2): | 0.769 |
hERG Blockers: | 0.014 | Human Hepatotoxicity (H-HT): | 0.047 |
Drug-inuced Liver Injury (DILI): | 0.041 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.01 | Maximum Recommended Daily Dose: | 0.018 |
Skin Sensitization: | 0.705 | Carcinogencity: | 0.137 |
Eye Corrosion: | 0.983 | Eye Irritation: | 0.969 |
Respiratory Toxicity: | 0.516 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000110 | 0.776 | D0E4WR | 0.565 | ||||
ENC000356 | 0.731 | D07ILQ | 0.564 | ||||
ENC000357 | 0.712 | D0O1PH | 0.506 | ||||
ENC000050 | 0.687 | D00AOJ | 0.500 | ||||
ENC000282 | 0.658 | D0Z5SM | 0.432 | ||||
ENC000608 | 0.653 | D00FGR | 0.427 | ||||
ENC000466 | 0.642 | D0Z5BC | 0.400 | ||||
ENC000280 | 0.627 | D00STJ | 0.397 | ||||
ENC001304 | 0.619 | D0P1RL | 0.385 | ||||
ENC001553 | 0.617 | D05ATI | 0.363 |